΁EAgatoxin IVA

<strong>ρEAgatoxin IVA</strong> <strong>Catalog number:</strong> MDP0632 <strong>CAS Number: </strong>937031-00-0 <strong>Sequence: </strong>Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cys-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-Gly-Cys-Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-Leu-Ala (Disulfide bonds between Cys4-Cys20, Cys12-Cys25, Cys19-Cys36, and Cys27-Cys34) <strong>Amount:</strong> 100 ug <strong>Molecular Weight:</strong> 5202 g/mol <strong>Supplied as:</strong> Powder <strong>Applications:</strong> molecular tool for various biochemical applications <strong>Storage:</strong> -20 °C <strong>WARNING:</strong> For in vitro Research Use Only. NOT for use on humans or animals. <strong>Grade:</strong> Biotechnology grade. All products are highly pure. <strong>References:</strong> 1: Sawamoto K, Álvarez González JV, Piechnik M, Otero FJ, Couce ML, Suzuki Y, Tomatsu S. Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management Int J Mol Sci. 2020 Feb 23;21(4):1517. 2: Regier DS, Oetgen M, Tanpaiboon P. Mucopolysaccharidosis Type IVA 2013 Jul 11 [updated 2021 Jun 17]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. 3: Rush RB, Rush SW. Faricimab for Treatment-Resistant Diabetic Macular Edema Clin Ophthalmol. 2022 Aug 24;16:2797-2801. 4: Rush RB, Rush SW. Intravitreal Faricimab for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration Clin Ophthalmol. 2022 Dec 9;16:4041-4046. 5: Khan S, Alméciga-Díaz CJ, Sawamoto K, Mackenzie WG, Theroux MC, Pizarro C, Mason RW, Orii T, Tomatsu S. Mucopolysaccharidosis IVA and glycosaminoglycans Mol Genet Metab. 2017 Jan-Feb;120(1-2):78-95. 6: Wood TC, Harvey K, Beck M, Burin MG, Chien YH, Church HJ, D'Almeida V, van Diggelen OP, Fietz M, Giugliani R, Harmatz P, Hawley SM, Hwu WL, Ketteridge D, Lukacs Z, Miller N, Pasquali M, Schenone A, Thompson JN, Tylee K, Yu C, Hendriksz CJ. Diagnosing mucopolysaccharidosis IVA J Inherit Metab Dis. 2013 Mar;36(2):293-307. 7: Haddley K. Elosulfase alfa Drugs Today (Barc). 2014 Jul;50(7):475-83. 8: Guo X, Ji J, Zhang J, Hou X, Fu X, Luo Y, Mei Z, Feng Z. Anti-inflammatory and osteoprotective effects of Chikusetsusaponin Ⅳa on rheumatoid arthritis via the JAK/STAT signaling pathway Phytomedicine. 2021 Dec;93:153801. 9: Introducing new group leaders: Iva Tchasovnikarova Mol Cell. 2022 Jan 20;82(2):232-233. <a href="https://pubmed.ncbi.nlm.nih.gov/35893488">10: Li D, Lv J, Shi M, Wang L, Yang T, Yang Y, Chen N. Low-Dimensional Nanomaterial Systems Formed by IVA Group Elements Allow Energy Conversion Materials to Flourish Nanomaterials (Basel). 2022 Jul 22;12(15):2521. </a> <br><strong>Products Related to ρEAgatoxin IVA can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>